patients have increased life expectancy due to the access to antiretroviral drugs
treatment. However the increasing age comes with increased risk to non communicable
diseases which include diabetes mellitus. However the prevalence of diabetes mellitus
amongst HIV patients has not been extensively studied in Zimbabwe. Thus we sought
to determine the prevalence of diabetes mellitus amongst HIV patients on antiretroviral
therapy treatment attending Parirenyatwa Group of Hospitals Opportunistic Infections
Clinic, Harare, Zimbabwe.
cross-sectional study was conducted at Parirenyatwa Group of Hospitals Opportunistic
Infections Clinic, Harare, Zimbabwe. All HIV patients (18 years and older) on antiretroviral
therapy attending Parirenyatwa Group of Hospitals Opportunistic Infections Clinic
during the study period were given information on the study. Only those who consented
to participate in the study were recruited. Demographic data was obtained from patients
by administration of questionnaires. Blood samples were collected for glycosylated
haemoglobin analysis on a Mispa-i2 Chemistry Analyser.
total of 60 HIV patients on antiretroviral therapy were recruited into the study,
33 (55%) were females and 27 (45%) were males. The mean age was 43.48 ± 10.3 years.
Majority of the patients (33.3%) were on tenofovir, lamivudine and efavirenz. The prevalence of diabetes mellitus
mellitus prevalence amongst the HIV patients on antiretroviral therapy treatment
was 8.3%. There is need for need to investigate the factors associated with diabetes
mellitus in HIV patients on antiretroviral therapy treatment and confirm the prevalence
in a study with a large sample size.
JA, Lambert EV, Badri M, West S, Maartens G, Levitt NS. Effect of nonnucleoside
reverse transcriptase inhibitor–based antiretroviral therapy on dysglycemia and
insulin sensitivity in South African HIV-infected patients. JAIDS J Acquir
Immune DeficSyndr. 2011; 57 (4):284–9.
HA. Prevalence of prediabetes in HIV-1 infected adults receiving antiretroviral
therapy in Addis Ababa, Ethiopia. Int J PharmaSci Res. 2015; 6 (2):440–3.
TN, Olenburg B, Setswe G, Elliott J, Nanayakkara V. Epidemiology of Comorbidity
of HIV/AIDS and Non-‐communicable Diseases in Developing
Countries: A systematic review. J Glob Health Care Syst. 2012; 2 (1).
AE, Yemane Shenkute T, ChenekeGebisa W. Diabetes mellitus and risk factors in
human immunodeficiency virus-infected individuals at Jimma University Specialized
Hospital, Southwest Ethiopia. Diabetes MetabSyndrObes Targets Ther. 2015 Apr; 197.
E, Smart LR, Kalluvya S, Kataraihya JB, Saleh AM, Obeid L, et al. Glucose
Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults. Pacheco
AG, editor. PLOS ONE. 2015 Aug 19; 10(8):e0134410.
K, Senekal M, Harbron J. Non-communicable disease risk factors and treatment
preference of obese patients in Cape Town. Afr J Prim Health Care Fam Med.
AK, Glesby MJ, Brown TT. Diagnosing and Managing Diabetes in HIV-Infected
Patients: Current Concepts. Clin Infect Dis. 2015 Feb 1; 60 (3):453–62.
D, Tanthuma G, Mushisha O, Kwadiba G, Chikuse F, Cary MS, et al. Diabetes
mellitus in HIV-infected patients receiving antiretroviral therapy. SAMJ South
Afr Med J. 2014; 104 (1):40–2.
LD, Mathiesen ER, Kronborg G, Pedersen C, Gerstoft J, Obel N. Risk of Diabetes
Mellitus in Persons with and without HIV: A Danish Nationwide Population-Based
Cohort Study. Atashili J, editor. PLoS ONE. 2012 Sep 12; 7 (9):e44575.
Y, Wang Z, Liu L, Zhang R, Zheng Y, Lu H. Prevalence of hyperglycemia among
adults with newly diagnosed HIV/AIDS in China. BMC Infect Dis. 2013; 13 (1):79.
International Expert Committee. International Expert Committee Report on the
Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care. 2009 Jul 1; 32
Health Organization. Use of glycated haemoglobin (HbA1c) in diagnosis of
diabetes mellitus: abbreviated report of a WHO consultation. 2011 [cited 2016
Oct 28]; Available from: http://apps.who.int/iris/handle/10665/70523